Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Kiely currently holds 225,433 shares of Amneal Pharmaceuticals, Inc. (AMRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Kiely has been a net seller of AMRX stock. They have purchased $86.6K and sold $295.4K worth of shares.
John Kiely's most recent insider trade was on Aug 27, 2025, when they sold 32,000 shares at $9.23 per share.
John Kiely serves as Executive at Amneal Pharmaceuticals, Inc. (AMRX). They have executed 16 insider transactions totaling $382.0K over their tenure at the company.
John Kiely holds the position of Executive at Amneal Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
John Kiely has shown a selling trading pattern, with $86.6K in total purchases and $295.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Kiely was on Aug 27, 2025, when they sold $295.4K worth of AMRX shares. This transaction involved 32,000 shares at $9.23 per share.
John Kiely currently owns 225,433 shares of Amneal Pharmaceuticals, Inc. (AMRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Kiely's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Kiely has 16 Form 4 filings on record as an insider at Amneal Pharmaceuticals, Inc..
Set alerts for John Kiely and 40,000+ other insiders.